Artemis Closes $254M Fund IV for Industrial Tech

Defense, life sciences and semiconductors are usually discussed through aircraft, therapies and chips. Artemis Capital Partners is investing behind the equipment that lets those systems work: RF components, freeze-drying instruments, optical engineering, metrology and other industrial technologies that customers notice most when they fail.

The Boston private equity firm announced the final close of Artemis Capital Partners IV, L.P. with $254M in commitments. The fund closed on September 1, 2026, after entering the market with a $250M offering amount in its original SEC filing, and it had acquired three platforms by the time Artemis announced the close on September 15.

What Artemis closed

Artemis Capital Partners IV is a final close, not a fundraising target, first close or interim update. The $254M figure represents total commitments to the vehicle. It should not be read as capital already invested, firmwide assets under management or proof of the fund's future performance.

The accounting history is unusually clear. Artemis filed a Form D in August 2024 with a $250M total offering amount and no capital sold. An August 2025 amendment kept the same offering amount and reported $75M sold to 37 investors. The final commitment total finished $4M above that filed target.

Artemis said existing limited partners returned and new investors joined the fund, but it did not name them or disclose individual commitments. The firm also did not publish Fund IV's fees, carry, leverage, duration, check sizes, return target, LP concentration or performance. Aviditi Advisors, Piper Sandler's private capital advisory group, served as sole placement agent, while Mintz served as legal counsel.

The strategy lives inside other products

Artemis was founded in 2010 to buy and build differentiated industrial technology manufacturers. The firm focuses on companies serving aerospace, defense, life sciences and semiconductor markets through technologies including RF and microwave systems, analytical instruments, testing and measurement, thermal management, optics and photonics, and diagnostics and discovery.

That mandate places Artemis one layer beneath many of the products that receive public attention. A satellite communication system may depend on a rotary joint most people will never see. A biologic may depend on a lyophilization process preserving stability. A semiconductor manufacturing tool may require optical engineering and metrology that can measure performance at tolerances where an ordinary inspection process becomes useless.

These are not interchangeable manufacturing businesses. They can share mission-critical customers and still carry different product cycles, qualification standards, engineering cultures and failure consequences. Artemis's investment case depends on specialization traveling across those differences without becoming a generic private equity playbook.

Three platforms show the operating range

Artemis said Fund IV had acquired three platforms by the close but did not identify them in the announcement. The firm's public transaction record since the fundraising process began includes three platform acquisitions whose timing aligns with that count. Because Artemis did not explicitly assign the companies to Fund IV in the close release, they are best understood as public examples of the strategy rather than definitive vehicle attribution.

Diamond Antenna and Microwave Corporation joined the portfolio in November 2024. The company develops RF rotary joints and integrated electro-mechanical subsystems used across radar, satellite and space communications, air traffic control and electronic warfare. Its products illustrate the combination Artemis seeks: narrow technical expertise attached to applications where reliability is part of the customer's operating risk.

Millrock Technology followed in September 2025. Millrock makes laboratory, pilot and production-scale freeze-drying instruments and process-development tools for pharmaceutical, biotech and diagnostic customers. The equipment sits inside the work of preserving biologics, vaccines, diagnostics and other products whose stability cannot be treated as a cosmetic feature.

Optikos became an Artemis platform in April 2026. The company combines optical design, engineering, manufacturing, assembly, metrology and testing for applications across defense, space, life sciences, medical devices and semiconductors. Houlihan Lokey's transaction record confirms the deal closed on April 22.

Together, the three examples make the fund's breadth more concrete. Artemis is not buying one product category. It is assembling exposure to the enabling machinery behind several strategic markets, with each platform requiring its own understanding of customers, quality, engineering talent and production capacity.

The people carrying the mandate

James Ward, Artemis's CEO and Partner, joined the firm in 2011 and now oversees its fund-level strategy and internal systems. Euan Milne, CIO and Partner, joined in 2017 and works across transactions, portfolio management, investment theses, operating-partner oversight and LP engagement. Peter A. Hunter founded the firm, though current materials reviewed for this article do not establish a present operating title beyond founder.

That leadership mix matters because industrial ownership is rarely confined to capital allocation. Artemis says its work includes strategy, operational support, management development and company building. The burden is to apply those capabilities without treating engineering-led businesses as financial models that happen to own factories.

The public record already shows how varied that job can become. Diamond's customers care about mission reliability across land, sea, air and space. Millrock's users work inside regulated scientific processes. Optikos sells technical depth across design, manufacturing and measurement. Each business can benefit from investment in people, equipment and expansion, but each can also lose trust if growth outruns the discipline that made the product valuable.

What the $254M changes

Fund IV gives Artemis more room to pursue platform acquisitions and build around them through product development, talent, capacity and add-on transactions. The close also increases the number of decisions the firm must make across markets where quality failures are expensive and customer relationships can take years to earn.

The useful signal is not that strategic end markets are popular. It is that investors backed a manager focused on the less visible manufacturers inside them. Those suppliers can sit far from the headline while remaining close to the operating consequence, whether that consequence is a radar system holding performance, a therapy surviving storage or an optical instrument measuring what a production line cannot afford to miss.

Artemis now has $254M in commitments and three acquired platforms behind the mandate. The next stage will unfold inside engineering teams, factory floors, qualification programs and customer relationships where the firm's specialization has to become more than a fundraising description.